Deans' stroke musings: Traditional Chinese Medicines in the management of cardiovascular diseases: a comprehensive systematic review

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, May 23, 2016

Traditional Chinese Medicines in the management of cardiovascular diseases: a comprehensive systematic review

Notice this says more research needed, do not start taking TCM because one anecdote from a friend suggests it works. With no idea of the active ingredients one ingredient could be useful, another could be dangerous.
http://www.ncbi.nlm.nih.gov/pubmed/27195823

Layne K¹, Ferro A¹.

Author information

Abstract

AIMS:

The aim was to perform a systematic review of the efficacy of Traditional Chinese Medicines (TCM) in cardiovascular disease.

METHODS:

Electronic databases were searched up to 11^th November 2015 for all randomised-controlled trials evaluating the effect of TCM in hypertension, ischaemic stroke, heart failure, coronary heart disease and type 2 diabetes mellitus. Pooled odds ratios (ORs) were calculated using a fixed-effects model.

RESULTS:

Four hypertension studies were eligible for statistical analysis and included 133 patients receiving TCM and 130 control patients. There were significant reductions in systolic blood pressure in patients receiving TCM, comparable to results achieved with pharmaceutical medicines. An OR of 3.781 (95% confidence interval 2.392, 5.977; p = 0.000) was observed for the anti-hypertensive effect of TCM. Significant heterogeneity was present (p = 0.011), with a tendency towards publication bias that did not reach significance (p = 0.05275). Outcome measures for other cardiovascular diseases were inconsistent.

CONCLUSIONS:

Certain TCM compounds appear to have significant anti-hypertensive effects, and although some are associated in some studies with improved outcomes in coronary heart disease, heart failure and type 2 diabetes mellitus the data are inconsistent and will require large-scale randomised-controlled trials to allow full evaluation of any potential therapeutic benefit in these areas.
This article is protected by copyright. All rights reserved.